THERAPEUTIC SEGMENT:
Gastroenterology 

INDICATIONS:
Gutfam (Famotidine) is indicated for:
• Short-term treatment of active duodenal and gastric ulcers
• Management of gastroesophageal reflux disease (GERD) and erosive esophagitis
• Treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome)

BRIEF DESCRIPTION:
Gutfam (Famotidine) is a competitive histamine-2 (H₂) receptor antagonist that inhibits gastric acid secretion by blocking H₂ receptors on gastric parietal cells, thereby reducing both the volume and acidity of gastric secretions. It provides effective relief in acid-related conditions such as ulcers and gastroesophageal reflux disease (GERD).

DOSAGE FORM:
Tablets
20mg
40mg